ストックスクリーナーアプリを入手
170.31
1.22%
2.05
アフターアワーズ：
170.31
Aptargroup Inc (ATR) 最新ニュース
AptarGroup, Inc. (NYSE:ATR) Shares Sold by New York State Common Retirement Fund - MarketBeat
Aptar Beauty Receives AVON Supplier Award With Micro Eco - Aptar
Give Consumers a Delightful Barbecue Experience this Summer with Aptar Food + Beverage’s Snap Top Closures - Aptar
This Insider Has Just Sold Shares In AptarGroup - Simply Wall St
DekaBank Deutsche Girozentrale Lowers Stock Position in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
AptarGroup Hits 52-Week High: What's Driving the Stock's Performance? - MSN
Congress Asset Management Co. Makes New Investment in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
Insider Sale: Segment President Marc Prieur Sells 4,000 Shares o - GuruFocus.com
AptarGroup segment president sells $673,136 in stock By Investing.com - Investing.com Australia
AptarGroup segment president sells $673,136 in stock - Investing.com
William Blair Has Negative Outlook of AptarGroup Q2 Earnings - MarketBeat
Aptargroup CEO Stephan Tanda sells $5.1 million in stock By Investing.com - Investing.com Canada
AptarGroup Q3 Earnings Beat Estimates, Revenues Increase Y/Y - MSN
Aptargroup CEO Stephan Tanda sells $5.1 million in stock - Investing.com India
AptarGroup, Inc. (NYSE:ATR) CEO Sells $5,088,000.00 in Stock - MarketBeat
William Blair Decreases Earnings Estimates for AptarGroup - MarketBeat
Assenagon Asset Management S.A. Has $5.91 Million Stock Holdings in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
Baird lifts AptarGroup stock target, outperform on strong growth outlook By Investing.com - Investing.com Canada
Baird lifts AptarGroup stock target, outperform on strong growth outlook - Investing.com
AptarGroup (NYSE:ATR) Price Target Increased to $185.00 by Analysts at Robert W. Baird - MarketBeat
Raymond James & Associates Lowers Stake in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
AptarGroup, Inc. (NYSE:ATR) Q3 2024 Earnings Call Transcript - MSN
Boston Trust Walden Corp Has $232.25 Million Stock Position in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
AptarGroup Inc (ATR) Q3 2024 Earnings Call Highlights: Strong Pharma Growth and Strategic ... - Yahoo Finance
AptarGroup Inc (ATR) Q3 2024 Earnings Call Highlights: Strong Ph - GuruFocus.com
Decoding AptarGroup Inc (ATR): A Strategic SWOT Insight - Yahoo Finance
Earnings call: Aptar reports growth and robust Pharma segment in Q3 - Investing.com Canada
AptarGroup (NYSE:ATR) Sets New 1-Year HighShould You Buy? - MarketBeat
AptarGroup stock soars to all-time high of $169.67 - Investing.com
AptarGroup Q3 24 Earnings Conference Call At 9:00 AM ET - Nasdaq
Schwartz Investment Counsel Inc. Has $43.25 Million Position in AptarGroup, Inc. (NYSE:ATR) - MarketBeat
AptarGroup: Q3 Earnings Snapshot - The Washington Post
AptarGroup (ATR) Surpasses Q3 Earnings Estimates - Yahoo Finance
AptarGroup Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
AptarGroup Inc (ATR) Q3 Earnings: EPS of $1.48 Beats Estimates, Revenue at $909 Million Misses Expectations - GuruFocus.com
Aptar Reports Third Quarter 2024 Results - Aptar
AptarGroup, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
AptarGroup Inc (ATR) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
AptarGroup Inc (ATR) Q3 2024 Earnings Report Preview: What To Ex - GuruFocus.com
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices - Aptar
AptarGroup About To Put More Money In Your Pocket (ATR) - Nasdaq
How Silk Helps Brands Create an Exclusive Fragrance Experience - Aptar
AptarGroup, Inc. (NYSE:ATR) Shares Sold by Inspire Investing LLC - MarketBeat
AptarGroup stock rises as Jefferies upgrades to Buy - MSN
Here's Why Momentum in AptarGroup (ATR) Should Keep going - Yahoo Finance
AptarGroup (NYSE:ATR) Rating Increased to Strong-Buy at Dbs Bank - MarketBeat
Zacks Research Research Analysts Increase Earnings Estimates for AptarGroup, Inc. (NYSE:ATR) - MarketBeat
AptarGroup (NYSE:ATR) PT Raised to $185.00 - MarketBeat
Cosmetic Packaging Market is Estimated to Grow at a CAGR of 3.6% through 2031, Report by SkyQuest Technology - Benzinga
2024 CDP Corporate Questionnaire - Aptar
Aptar CSP’s N-Sorb Accepted To FDA’s Emerging Tech Program - Contract Pharma
0.98%
5.88%
大文字化:
|
ボリューム (24 時間):